The Inflation Reduction Act (IRA) allows the Centers for Medicare and Medicaid Services to negotiate drug prices. However, CMS can only negotiated drug prices 9 years after drug approval for small molecules and 13 years after approval for large molecules. Why the difference? Do biologic treatments produce superior health benefits for patients? This is the…
The Trump administration has given notice that political appointees, rather than scientists, will ultimately decide who gets grant money from the world’s largest biomedical research funder — the federal government’s National Institutes of Health. In an Aug. 7 executive order, President Donald Trump announced that political officers would have the power to summarily cancel any…
Ohio Republican Sen. JD Vance and Minnesota Democratic Gov. Tim Walz met in an Oct. 1 vice presidential debate hosted by CBS News that was cordial and heavy on policy discussion — a striking change from the Sept. 10 debate between Vice President Kamala Harris and former President Donald Trump. Vance and Walz acknowledged occasional agreement on…
Obesity and type 2 diabetes are among the cardiometabolic diseases included in Novo Nordisk’s R&D pact with Replicate Biosciences, a deal that could pay out up to $550 million. Startup Replicate specializes in therapies and vaccines based on self-replicating RNA. The post Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines appeared…
During cheerleading practice in April, Jana Duey’s sixth grade daughter, Karter, sustained a concussion when she fell several feet headfirst onto a gym floor mat. Days after, Karter still had a headache, dizziness, and sensitivity to light and noise. Karter rested for a week and a half at home in Centennial, Colorado, then returned to…
The ‘Sutter Sync’ devices will support patients managing Type 2 diabetes, high blood pressure and those who are pregnant
Michael Cannon makes the convincing case that the answer is a resounding ‘no’. Those who say that private health insurance companies are evil entities that profit from denying health care to patients fail to appreciate that private health insurance companies are in fact a wondrous force for good.Outrageous? Not at all. Health insurance companies get…
This brief provides an overview of DACA and who DACA recipients are and provides estimates of health coverage, work status, and income among individuals who meet eligibility criteria for DACA.
KFF Health News senior correspondent Angela Hart discussed California Gov. Gavin Newsom’s health legacy on KVPR’s “Central Valley Daily” on Jan. 16 and on KQED’s “Forum” on Jan. 13. Click here to hear Hart on “Central Valley Daily” Click here to hear Hart on “Forum” Read Hart and Christine Mai-Duc’s “Health Care Is Newsom’s Biggest…
This updated chart collection compares indicators of health care utilization and prices in the United States and 11 similarly wealthy countries to investigate whether higher prices or higher utilization of healthcare services drives the high healthcare expenditures in the U.S. relative to peer nations.